PKTX — ProtoKinetix, Inc.
—
·
Health Care ·
Pharmaceuticals ·
CIK 1128189 ·
Last close
$0.00
Market Cap
$82.3K
52W High
$0.01
52W Low
$0.00
ADV30
2,790
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -119,988 | -119,988 | 483,374 | 1,118 | 185,434 |
| Sep 2025 | 0 | — | -84,906 | -84,906 | 477,623 | 607 | 227,196 |
| Jun 2025 | 0 | — | -91,067 | -91,067 | 474,417 | 112 | 149,084 |
| Mar 2025 | 0 | — | -97,690 | -97,690 | 528,625 | 49,477 | 152,225 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-181,177
Investing CF
$-41,406
Financing CF
$217,500
CapEx
$-41,406
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-09-06
Balance + Analyst (yfinance extras)
Retained Earnings
$-48,501,809
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-376,175
Pretax Income TTM
$-376,175
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -393,650 | -393,650 | 483,374 | 185,434 | 297,940 | -135,377 |
| Dec 2024 | 0 | -364,188 | -364,188 | 466,000 | 124,000 | 342,090 | -223,050 |
| Dec 2023 | 0 | -415,479 | -415,479 | 481,000 | 44,696 | 435,861 | -375,989 |
| Dec 2022 | 0 | -1,907,309 | -1,907,309 | 463,000 | 41,530 | 421,340 | -804,669 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OWPC | One World Products, Inc. | $96.1K | $0.00 | — |
| AVCRF | Avricore Health Inc. | $101.1K | $0.00 | — |
| BDPT | BIOADAPTIVES, INC. | $57.6K | $0.00 | — |
| PRPH | ProPhase Labs, Inc. | $155.9K | $0.01 | — |
| CNBX | CNBX Pharmaceuticals Inc. | $160.6K | $0.00 | — |
Recent Insider Activity
No insider activity indexed for this ticker.